New Avenues of Exploration for Erythropoietin
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Discovery that the hormone erythropoietin (EPO) and its receptor play a significant biological role in tissues outside of the hematopoietic system has fueled significant interest in EPO as a novel cytoprotective agent in both neuronal and vascular systems. Erythropoietin is now considered to have applicability in a variety of disorders that include cerebral ischemia, myocardial infarction, and chronic congestive heart failure. Erythropoietin modulates a broad array of cellular processes that include progenitor stem cell development, cellular integrity, and angiogenesis. As a result, cellular protection by EPO is robust and EPO inhibits the apoptotic mechanisms of injury, including the preservation of cellular membrane asymmetry to prevent inflammation. As the investigation into clinical applications for EPO that maximize efficacy and minimize toxicity progresses, a deeper appreciation for the novel roles that EPO plays in the brain and heart and throughout the entire body should be acquired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2003) · Blood · doi:10.1182/blood-2003-01-0223 · Cited by 845
Shingo, T., Sorokan, S. T., Shimazaki, T., & Weiss, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09733.2001 · Cited by 653
Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644
Erythropoietin receptor mRNA expression in human endothelial cells.
Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E. S., Kessimian, N., & Noguchi, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3974 · Cited by 570
A novel protective effect of erythropoietin in the infarcted heart
Parsa, C. J., Matsumoto, A., Kim, J., Riel, R. U., Pascal, L. S., Walton, G. B., Thompson, R. B., Petrofski, J. A., Annex, B. H., Stamler, J. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18200 · Cited by 548
Mancini, D. M., Katz, S. D., Lang, C. C., LaManca, J., Hudaihed, A., & Androne, A.-S. (2003) · Circulation · doi:10.1161/01.cir.0000044914.42696.6a · Cited by 542
Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell’Era, P., Nico, B., Roncali, L., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.8.2627 · Cited by 538
Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., & Remé, C. E. (2002) · Nature Medicine · doi:10.1038/nm723 · Cited by 518
Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462
Pure Red-Cell Aplasia and Epoetin Therapy
Bennett, C. L., Luminari, S., Nissenson, A. R., Tallman, M. S., Klinge, S. A., McWilliams, N., McKoy, J. M., Kim, B., Lyons, E. A., Trifilio, S. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040528 · Cited by 437
Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Circulation · doi:10.1161/01.cir.0000039103.58920.1f · Cited by 381
Self-citationErythropoietin and VEGF Exhibit Equal Angiogenic Potential
Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., & Kuck, K.-H. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2426 · Cited by 317
Moon, C., Krawczyk, M., Ahn, D., Ahmet, I., Paik, D., Lakatta, E. G., & Talan, M. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1930406100 · Cited by 301
Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J., & Schulz, J. B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06401.2002 · Cited by 283
Silverberg, D. S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.1.141 · Cited by 258
Kawakami, M., Sekiguchi, M., Sato, K., Kozaki, S., & Takahashi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105832200 · Cited by 251
Recombinant human erythropoietin stimulates angiogenesis in vitro
Carlini, R. G., Reyes, A. A., & Rothstein, M. (1995) · Kidney International · doi:10.1038/ki.1995.113 · Cited by 245
Chong, Z. Z., Kang, J., & Maiese, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705161 · Cited by 237
Self-citationChong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200205000-00001 · Cited by 200
Self-citationCai, Z., & Semenza, G. L. (2004) · Circulation · doi:10.1161/01.cir.0000127954.98131.23 · Cited by 199
Kumral, A., Uysal, N., Tugyan, K., Sonmez, A., Yilmaz, O., Gokmen, N., Kiray, M., Genc, S., Duman, N., Koroglu, T. F., et al. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.002 · Cited by 191
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure
van der Meer, P., Voors, A. A., Lipsic, E., Smilde, T. D. J., van Gilst, W. H., & van Veldhuisen, D. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.052 · Cited by 190
Cardioprotective Effects of Erythropoietin in the Reperfused Ischemic Heart
Parsa, C. J., Kim, J., Riel, R. U., Pascal, L. S., Thompson, R. B., Petrofski, J. A., Matsumoto, A., Stamler, J. S., & Koch, W. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314099200 · Cited by 186
Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.
Chong, Z. Z., Li, F., & Maiese, K. (2005) · PubMed · doi:10.14670/hh-20.299 · Cited by 182
Self-citationErythropoietin in the brain: can the promise to protect be fulfilled?
Maiese, K., Li, F., & Chong, Z. Z. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.09.006 · Cited by 179
Self-citationChong, Z. Z., Kang, J.-Q., & Maiese, K. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200303000-00007 · Cited by 169
Self-citationKaptanoğlu, E., Solaroğlu, İ., Okutan, Ö., Surucu, H. S., Akbıyık, F., & Beşkonaklı, E. (2004) · Neurosurgical Review · doi:10.1007/s10143-003-0300-y · Cited by 163
Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability
Martínez‐Estrada, O. M., Rodríguez‐Millán, E., González‐de Vicente, E., Reina, M., Vilaró, S., & Fabre, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02987.x · Cited by 161
Chong, Z. Z., Lin, S., Kang, J., & Maiese, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10528 · Cited by 157
Self-citationIncreased Cerebral Infarct Volumes in Polyglobulic Mice Overexpressing Erythropoietin
Wiessner, C., Allegrini, P. R., Ekatodramis, D., Jewell, U. R., Stallmach, T., & Gassmann, M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200107000-00011 · Cited by 154
Beneficial and ominous aspects of the pleiotropic action of erythropoietin
JELKMANN, W. E. B., & Wagner, K. F. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0911-6 · Cited by 145
Chong, Z. Z., Lin, S.-H., & Maiese, K. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000122746.72175.0e · Cited by 139
Self-citationDzietko, M., Felderhoff-Mueser, U., Sifringer, M., Krutz, B., Bittigau, P., Thor, F., Heumann, R., Bührer, C., Ikonomidou, C., & Hansen, H. H. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.006 · Cited by 139
Angiogenesis and Plasticity: Role of Erythropoietin in Vascular Systems
Chong, Z. Z., Kang, J., & Maiese, K. (2002) · Stem Cells and Development · doi:10.1089/152581602321080529 · Cited by 130
Self-citationMahmud, D. L., G-Amlak, M., Deb, D. K., Platanias, L. C., Shahab Uddin, M. S., & Wickrema, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205230 · Cited by 123
Kang, J., Chong, Z. Z., & Maiese, K. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.557 · Cited by 116
Self-citationErythropoietin as a novel neuroprotectant.
Genç, Ş., Köroğlu, T., & Genç, K. (2004) · PubMed · Cited by 113
Somervaille, T. C. P., Linch, D. C., & Khwaja, A. (2001) · Blood · doi:10.1182/blood.v98.5.1374 · Cited by 110
Verdier, F., Walrafen, P., Hubert, N., Chrétien, S., Gisselbrecht, S., Lacombe, C., & Mayeux, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.24.18375 · Cited by 105
Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function
Ajmani, R. S., Metter, E. J., Rajadas, J., Ingram, D. K., Spangler, E. L., Abugo, O. O., & Rifkind, J. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00118-4 · Cited by 104
Chong, Z. Z., Kang, J., & Maiese, K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.021 · Cited by 95
Self-citationGoldberg, N., Lundin, A. P., Delano, B. G., Friedman, E. A., & Stein, R. A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90608-x · Cited by 93
Epoetin Alfa: Clinical Evolution of a Pleiotropic Cytokine
Henry, D. H., Bowers, P., Romano, M. T., & Provenzano, R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.262 · Cited by 91
Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease.
Maiese, K., & Chong, Z. Z. (2004) · PubMed · Cited by 77
Self-citationHewitson, K. S., McNeill, L. A., & Schofield, C. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452884 · Cited by 64
Central Nervous System Frontiers for the Use of Erythropoietin
Olsen, N. V. (2003) · Clinical Infectious Diseases · doi:10.1086/376912 · Cited by 42
Regulation of Endothelial Cell Death and Its Role in Angiogenesis and Vascular Regression
Sakamaki, K. (2004) · Current Neurovascular Research · doi:10.2174/1567202043362072 · Cited by 35
Researchers Probe Anemia–Heart Failure Link
Mitka, M. (2003) · JAMA · doi:10.1001/jama.290.14.1835 · Cited by 19
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Efficacy and Safety of Epoetin Alfa in Critically Ill Patients
Corwin, H. L., Gettinger, A., Fabian, T. C., May, A., Pearl, R. G., Heard, S., An, R., Bowers, P. J., Burton, P., Klausner, M. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071533 · Cited by 545
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Self-citationPathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2229 · Cited by 257
Interventions for protecting renal function in the perioperative period
Zacharias, M., Mugawar, M., Herbison, G. P., Walker, R. J., Hovhannisyan, K., Sivalingam, P., & Conlon, N. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003590.pub4 · Cited by 232
Metadata
- Authors
- Maiese, K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-01-05
- Volume
- 293
- Issue
- 1
- Pages
- 90
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2028628328
- Cited by
- 528
- References
- 49
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.